Form 4: Astronics Corp. CEO Peter Gundermann Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Peter Gundermann, President and CEO of Astronics Corp., reports acquisition and disposal of common stock and stock options related to bonus plans and tax obligations.
Summary
- Peter Gundermann, the President and CEO of Astronics Corp., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- The report includes the acquisition of 276 shares and 19,817 shares of common stock as part of the 2023 bonus plan payout, paid in shares instead of cash.
- A total of 82 and 4,959 shares were withheld to cover applicable withholding taxes upon the grant of the stock bonus award.
- Gundermann also holds various stock options with exercise prices ranging from $9.74 to $35.61 and expiration dates between 2024 and 2033.
- He also holds restricted stock units (RSUs) that vest based on Astronics Corp.'s average annual adjusted EBITDA over different periods, with vesting percentages varying based on performance.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing detailing stock transactions related to compensation. The vesting of RSUs based on EBITDA is a positive sign, but overall, the document doesn't strongly indicate positive or negative sentiment.
Positives
- The acquisition of shares as part of the bonus plan indicates confidence in the company's future performance.
- The vesting of restricted stock units is tied to the company's EBITDA performance, aligning management's interests with those of shareholders.
Risks
- The vesting of restricted stock units is contingent on achieving specific EBITDA targets, which may not be met.
- Fluctuations in the company's stock price could impact the value of the stock options and restricted stock units.
Future Outlook
The vesting of restricted stock units is tied to future EBITDA performance, suggesting a focus on improving profitability.
Industry Context
Insider transactions are closely monitored as they can provide insights into management's perspective on the company's prospects. This filing is a routine disclosure required by the SEC.
Comparison to Industry Standards
- Stock option and RSU grants are common forms of executive compensation in the aerospace and defense industry, used by companies like Boeing, Lockheed Martin, and Raytheon to incentivize performance.
- Vesting schedules tied to EBITDA or other financial metrics are also standard practice to align management's interests with shareholder value.
- The specific terms of the grants, such as exercise prices and vesting percentages, are company-specific and depend on factors like company size, performance, and industry benchmarks.
Stakeholder Impact
- Shareholders may be interested in the CEO's stock transactions as an indicator of his confidence in the company.
- Employees may be impacted by the EBITDA-based vesting of restricted stock units, as it ties their compensation to the company's financial performance.
Key Dates
| Date | Description |
|---|---|
| 12/11/2015 | Date of grant for some stock options with an exercise price of $30.83. |
| 12/03/2016 | Date of grant for some stock options with an exercise price of $27.72. |
| 12/14/2017 | Date of grant for some stock options with an exercise price of $31.76. |
| 12/12/2018 | Date of grant for some stock options with an exercise price of $35.61. |
| 12/13/2019 | Date of grant for some stock options with an exercise price of $31.57. |
| 12/09/2020 | Date of grant for some stock options with an exercise price of $30.04. |
| 01/01/2021 | Start date for the period used to determine vesting of some restricted stock units. |
| 01/22/2022 | Date of grant for some stock options with an exercise price of $14.45. |
| 01/01/2022 | Start date for the period used to determine vesting of some restricted stock units. |
| 12/09/2022 | Date of grant for some stock options with an exercise price of $11.13. |
| 01/01/2023 | Start date for the period used to determine vesting of some restricted stock units. |
| 12/16/2023 | Date of grant for some stock options with an exercise price of $9.74. |
| 12/31/2023 | Date on which some restricted stock units vested, based on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2021 December 31, 2023. |
| 01/01/2024 | Start date for the period used to determine vesting of some restricted stock units. |
| 03/01/2024 | Date of the transactions reported in the Form 4. |
| 12/07/2024 | Date of grant for some stock options with an exercise price of $15.15. |
| 02/24/2025 | Date on which some restricted stock units may vest, based on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2022 December 31, 2024. |
| 02/23/2026 | Date on which some restricted stock units may vest, based on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2023 December 31, 2025. |
| 02/23/2027 | Date on which some restricted stock units may vest, based on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2024 December 31, 2026. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.